跳至主要内容
临床试验/NCT01510886
NCT01510886已完成不适用

Assessment of MDD Management Strategies in Andalusia: A Sub-analysis of the PismaEP Study

AstraZeneca1 个研究点 分布在 1 个国家目标入组 5,309 人开始时间: 2012年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
5,309
试验地点
1
主要终点
Number of Referrals

研究概览

简要总结

The main objectives of this study are to describe medical professionals responsible of the management of patients with MDD in a representative region of Andalusia (in terms of type of sites managing the disease, and referral to SC criteria); Describe MDD patient characteristics at inclusion in the PISMA-Ep Study; and to evaluate those factors associated to a higher incidence of referral from PC to SC.

详细描述

Assessment of MDD management strategies in Andalusia: A Sub-analysis of the PismaEP Study

研究设计

研究类型
Observational
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • MDD Diagnosis Participants of the PismaEP study 18 yo. or older

排除标准

  • No specific exclusion criteria

结局指标

主要结局

Number of Referrals

时间窗: From Jan 2010 to Jan 2011

Number of Visits to Primary Care

时间窗: From Jan 2010 to Jan 2011

Number of Visits to Secondary Care

时间窗: From Jan 2010 to Jan 2011

次要结局

  • Demographics(From Jan 2010 to Jan 2011)
  • Type of site(From Jan 2010 to Jan 2011)
  • Severity of disease(From Jan 2010 to Jan 2011)
  • Type of therapeutic strategy(From Jan 2010 to Jan 2011)
  • Type of disease(From Jan 2010 to Jan 2011)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验